North America Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019

The report analyzes the North American orthobiologics market by type, end-user, and geography. By end-users the North American orthobiologics market is categorized into hospitals, point of care testing (POCT), and other end-users. The geographies covered are the U.S., Canada, and Mexico. The North American orthobiologics market registered the largest market share of 43.6% in 2014 and it is estimated to grow at a CAGR of 7.7% for the forecast period 2014 to 2019.

In the North American orthobiologics market, the U.S. occupies the largest market share due to factors such as rising awareness among people about the benefits of orthobiologics and their changing preference from mechanical implants to biological implants. It is followed by Canada, which registered a CAGR of 8.3%. Mexico is also a developing market with a growth rate of 7.9%.

The factors contributing to the growth of the North American orthobiologics market are increasing awareness among people about the benefits associated with orthobiologics- which includes faster bone healing, reduction in the number of hospital visits, and quicker recovery. There is also increased awareness among people with respect to the technological advancements in this field. New product launches are also fuelling the growth of this market.

In February 2012, Zimmer Holdings, Inc. announced launch of Chondrofix Osteochondral Allograft, a product that helps in the treatment of osteochondral lesions using a single stage process. The product helped the company expand its range of musculoskeletal products.

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders, such as, CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.

Some of the key market players of the North American orthobiologics market include Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra LifeSciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer Holdings, Inc. (U.S.), Tornier, Inc. (Netherlands), NuVasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Group, Inc. (U.S.).

Table of Contents

1 Introduction (Page No. - 10)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 12)
    2.1 Integrated Ecosystem of Orthobiologics Market
    2.2 Arriving at the North America Orthobiologics Market Size
           2.2.1 Top-Down Approach
           2.2.2 Macro Indicator-Based Approach
    2.3 Assumptions

3 Executive Summary (Page No. - 17)

4 Market Overview (Page No. - 19)
    4.1 Introduction
    4.2 Orthobiologicals Market: Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics

5 North America Orthobiologics Market, By Product (Page No. - 25)
    5.1 Introduction
    5.2 North America Bone Graft Substitutes Market, By Country, 2013-2019 (USD MN)
    5.3 North America Stem Cell Therapy Market, By Country, 2013-2019 (USD MN)
    5.4 North America Bone Allografts Market, By Country, 2013 – 2019 (USD MN)
    5.5 North America Viscosupplementation Market, By Country, 2013-2019 (USD MN)
    5.6 North America Bone Growth Factor and Spinal Stimulation Market, By Country, 2013-2019 (USD MN)

6 North America Orthobiologics Market, By End User (Page No. - 37)
    6.1 Introduction
    6.2 North America Hospitals Market
    6.3 North America Point of Care (POC) Testing Market
    6.4 North America Other End Users Market

7 North America Orthobiologics Market, By Geography (Page No. - 43)
    7.1 Introduction
    7.2 U.S. Orthobiologics Market
           7.2.1 U.S. Orthobiologics Market, By Product
           7.2.2 U.S. Orthobiologics Market, By End User
           7.3.1 Canada Orthobiologics Market, By Product, 2013-2019 (USD MN)
           7.3.2 Canada Orthobiologics Market, By End User
           7.4.1 Mexico Orthobiologics Market, By Product, 2013-2019 (USD MN)
           7.4.2 Mexico Orthobiologics Market, By End User, 2013-2019 (USD MN)

8 Orthobiologics Market: Competitive Landscape (Page No. - 59)
    8.1 Orthobiologics Market: Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 New Product Launches
    8.4 Expansions
    8.5 Agreements
    8.6 Other Developments

9 Orthobiologics Market, By Company (Page No. - 66)
    9.1 Biomet, Inc.
           9.1.1 Overview
           9.1.2 Key Financials
           9.1.3 Product and Service Offerings
           9.1.4 Related Developments
    9.2 Medtronic Plc
           9.2.1 Overview
           9.2.2 Key Financials
           9.2.3 Product and Service Offerings
           9.2.4 Related Developments
    9.3 Integra Life Sciences Corporation
           9.3.1 Overview
           9.3.2 Key Financials
           9.3.3 Product and Service Offerings
           9.3.4 Related Developments
    9.4 Stryker Corporation
           9.4.1 Overview
           9.4.2 Key Financials
           9.4.3 Product and Service Offerings
           9.4.4 Related Developments
    9.5 Zimmer, Inc.
           9.5.1 Overview
           9.5.2 Key Financials
           9.5.3 Product and Service Offerings
           9.5.4 Related Developments
    9.6 Tornier, Inc.
           9.6.1 Overview
           9.6.2 Key Financials
           9.6.3 Product and Service Offerings
           9.6.4 Related Developments
    9.7 Nuvasive, Inc.
           9.7.1 Overview
           9.7.2 Key Financials
           Sources: Secondary Research, Company Annual Reports, Press Releases, and Micromarketmonitor
           Analysis
           9.7.3 Products and Service Offerings
           9.7.4 Related Developments
    9.8 Exactech, Inc.
           9.8.1 Overview
           9.8.2 Key Financials
           9.8.3 Products and Service Offerings
           9.8.4 Related Developments
    9.9 Globus Medical Inc.
           9.9.1 Overview
           9.9.2 Key Financials
           9.9.3 Products and Service Offerings
           9.9.4 Related Developments
    9.10 Wright Medical Technology, Inc.
           9.10.1 Overview
           9.10.2 Key Financials
           9.10.3 Products and Service Offerings
           9.10.4 Related Developments

10 Appendix (Page No. - 97)
     10.1 Customization Options
             10.1.1 Regulatory Framework
             10.1.2 Impact Analysis
             10.1.3 Trade Analysis
             10.1.4 Historical Data and Trends
     10.2 Related Reports
     10.3 Introducing RT: Real Time Market Intelligence
             10.3.1 RT Snapshots

List of Tables (37 Tables)

Table 1 North America Orthobiologics Market: Macro Indicator,  By Country, 2011 - 2013
Table 2 North America Orthobiologicals Market: Comparison  With Parent Market, 2013 – 2019 (USD MN)
Table 3 North America Orthobiologics Market: Drivers and Inhibitors
Table 4 North America Nitrogenous Fertilizers Market, By Type,  2013 - 2019 (USD MN)
Table 5 North America Orthobiologics Market, By Product, 2013-2019 (USD MN)
Table 6 North America Bone Graft Substitutes Market, By Country, 2013-2019 (USD MN)
Table 7 North America Stem Cell Therapy Market, By Country, 2013-2019 (USD MN)
Table 8 North America Bone Allografts Market, By Country, 2013-2019 (USD MN)
Table 9 North America Viscosupplementation Market, By Country, 2013-2019 (USD MN)
Table 10 North America Bone Growth Factor and Spinal Stimulation Market, By Country, 2013-2019 (USD MN)
Table 11 North America Orthobiologics Market, By End User, 2013-2019 (USD MN)
Table 12 North America Hospitals Market, By Country, 2013–2019 (USD MN)
Table 13 North America Point of Care (POC) Testing Market, By Country, 2013 - 2019 (USD MN)
Table 14 North America Other End Users Market, By Country, 2013 - 2019 (USD MN)
Table 15 North America Orthobiologics Market, By Geography,  2013 - 2019 (USD MN)
Table 16 U.S. Orthobiologics Market, By Product, 2013-2019 (USD MN)
Table 17 U.S. Orthobiologics Market, By End User, 2013-2019 (USD MN)
Table 18 Canada Orthobiologics Market, By Product, 2013-2019 (USD MN)
Table 19 Canada Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Table 20 Mexico Orthobiologics Market, By Product, 2013-2019 (USD MN)
Table 21 Mexico Orthobiologics Market, By End User, 2013-2019 (USD MN)
Table 22 Orthobiologics Market: Company Share Analysis, 2013 (%)
Table 23 North America Orthobiologics Market: Mergers & Acquisitions
Table 24 North America Orthobiologics Market: New Product Launches
Table 25 North America Orthobiologics Market: Expansions
Table 26 North America Orthobiologics Market: Agreements
Table 27 North America Orthobiologics Market: Other Developments
Table 28 Biomet, Inc.: Key Financials, 2011 - 2013 (USD MN)
Table 29 Medtronic, Plc.: Key Financials, 2009 - 2013 (USD MN)
Table 30 Integra Life Sciences Corporation: Key Financials, 2010 - 2013 (USD MN)
Table 31 Stryker Corporation: Key Financials, 2009 - 2013 (USD MN)
Table 32 Zimmer, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 33 Tornier, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 34 Nuvasive, Inc.: Key Financials, 2009 – 2013 (USD MN)
Table 35 Exactech, Inc.: Key Financials, 2009 -2013 (USD MN)
Table 36 Globus Medical, Inc.: Key Financials, 2009 -2013 (USD MN)
Table 37 Wright Medical Technology, Inc.: Key Financials, 2011 -2013 (USD MN)

List of Figures (47 Figures)

Figure 1 North America Orthobiologics Market: Segmentation & Coverage
Figure 2 Nitrogenous Fertilizers Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Macro Indicator-Based Approach
Figure 5 North America Orthobiologics Market Snapshot
Figure 6 North America Orthobiologics Market Size, By Country,  2014 (USD MN)
Figure 7 North America Orthobiologics Market, By Product (USD MN)
Figure 8 North America Bone Graft Substitutes Market, By Country, 2013-2019 (USD MN)
Figure 9 North America Stem Cell Therapy Market, By Country, 2013-2019 (USD MN)
Figure 10 North America Bone Allografts Market, By Country, 2013 – 2019 (USD MN)
Figure 11 North America Viscosupplementation Market, By Country, 2013-2019 (USD MN)
Figure 12 North America Bone Growth Factor and Spinal Stimulation Market, By Country, 2013-2019 (USD MN)
Figure 13 North America Orthobiologics Market, By End User, Market Comparison, 2014 & 2019 (USD MN)
Figure 14 North America Hospitals Market, By Geography, 2013–2019 (USD MN)
Figure 15 North America Point of Care (POC) Testing Market, By Country, 2013 – 2019 (USD MN)
Figure 16 North America Other End Users Market, By Country, 2013 - 2019 (USD MN)
Figure 17 North America Nitrogenous Fertilizers Market: Growth Analysis, By Geography, 2012-2018 (USD MN)
Figure 18 U.S. Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 19 U.S. Orthobiologics Market, By Product, 2013-2019 (USD MN)
Figure 20 U.S. Orthobiologics Market, By End User, 2013-2019 (USD MN)
Figure 21 Canada Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 22 Canada Orthobiologics Market, By Product, 2013-2019 (USD MN)
Figure 23 Canada Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 24 Mexico Orthobiologics Market, Market Overview 2014 & 2019 (%)
Figure 25 Mexico Orthobiologics Market, By Product, 2013-2019 (USD MN)
Figure 26 Mexico Orthobiologics Market, By End User, 2013-2019 (USD MN)
Figure 27 Orthobiologics Market: Company Share Analysis, 2013 (%)
Figure 28 Biomet, Inc.: Reveue Mix, 2013 (%)
Figure 29 Contribution of Spine, Bone Healing, & Microfixation Segment Towards Company Revenues, 2011-2013 (USD MN)
Figure 30 Medtronic, Plc. Revenue Mix, 2013 (%)
Figure 31 Contribution of Restorative Therapies Group Segment Towards Company Revenues, 2009-2013 (USD MN)
Figure 32 Integra Life Sciences Corporation Revenue Mix, 2013 (%)
Figure 33 Contribution of U.S. Spine and Other Segment Towards Company Revenues, 2010-2013 (USD MN)
Figure 34 Stryker Corporation Revenue Mix, 2013 (%)
Figure 35 Contribution of Reconstructive Segment Towards Company Revenues, 2010-2013 (USD MN)
Figure 36 Zimmer, Inc.:  Revenue Mix, 2013 (%)
Figure 37 Contribution of U.S. Spine and Other Segment Towards Company Revenues, 2010-2013 (USD MN)
Figure 38 Tornier, Inc.: Revenue Mix 2013 (%)
Figure 39 Contribution of Extremities Segment Towards Company Revenues, 2009-2013 (USD MN)
Figure 40 Nuvasive, Inc.: Revenue Mix 2013 (%)
Figure 41 Contribution of Biologics Segment Towards Company Revenues, 2009 - 2013 (USD MN)
Figure 42 Exactech, Inc.: Revenue Mix 2013 (%)
Figure 43 Contribution of Biologics & Spine Segment Towards Company Revenues, 2009 - 2013 (USD MN)
Figure 44 Globus Medical, Inc.: Revenue Mix 2013 (%)
Figure 45 Contribution of Disruptive Technology Segment Towards Company Revenues, 2009 - 2013 (USD MN)
Figure 46 Wright Medical Technology, Inc.: Revenue Mix 2013 (%)
Figure 47 Contribution of Biologics Segment Towards Company Revenues, 2011 - 2013 (USD MN)

Orthobiologics are defined as the substances of biological origin which facilitate the bone healing process in a better and more efficient manner. The normal bone healing process involves repositioning of the injured or fractured bone surgically or by immobilization of the dislocated bone and waiting for the body’s normal bone healing process to heal the bone and reposition it in its appropriate place. The importance of orthobiologics is highlighted due to the fact that orthobiologics products accelerate the natural bone healing process, thereby ensuring faster bone healing without facing any immunological barriers. 

Orthobiologics have started experiencing substantial growth since 2012 owing to the rise in the number of osteoarthritis and osteoporosis patients in this region, technological advancements in the research and development related to orthobiologics. Orthobiologics provide an effective alternative to the mechanical bone implants which take relatively longer time to reposition and heal the bone. Orthobiologics involve products that are derived from the patient’s own body and hence can match easily without facing any immunological barrier. Due to this feature, the healing process gets catalyzed and bone healing happens at a faster pace. Also, orthobiologics possess very few disadvantages because of which the demand for these products has been increasing continuously, and is expected grow rapidly in the future.

The North America orthobiologics market was valued at $1,724.5 million in 2014, and is expected to reach $2,493.5 million by 2019 at a CAGR of 7.7% from 2014 to 2019. The North American orthobiologics market has been segmented on the basis of product, end-user, and country. Orthobiologics market comprises products such as bone graft substitutes, stem cell therapy, bone allografts, viscosupplementation, and bone growth factor & spinal stimulation. The market has been further segmented on the basis of end-users into hospitals, Point of Care (POC) testing, and other end users. The North America Orthobiologics market consists of countries such as the U.S., Canada, and Mexico. 

The key players operating in this market are Biomet, Inc. (U.S.), Medtronic (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (The Netherlands), DJO Global (U.S.), NuVasive (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), Wright Medical Technology, Inc. (U.S.), and others.